irinotecanpancreatic cancercolorectal cancerCRCUGT1A1PC
…etabolizers is not affected by an upfront 30% dose reduction of irinotecan. Therefore, UGT1A1 genotype-guided dosing of irinotecan can be …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 123 of 2459edoxabanatrial fibrillationChronic stable Coronary Artery DiseaseEPIC-CAD trialdual antithrombotic therapy
… criteria were included; of whom, 121 patients (17.4%) received edoxaban underdosing. At 12 months, the incidence of primary outcome was…
ir-hepatitisUrsodeoxycholic acidmycophenolate mofetilmethylprednisoloneMMFImmune-related hepatitisClinicalTrials.gov
… T cell clonal expansion in a patient with steroid-unresponsive ir-hepatitis than in a steroid responder.Conclusion Nearly half of patients …
6MHPhigh-risk melanomaCDX-1140melanomamBRAFNCT04364230poly-ICLC
…ssess safety and immunogenicity. Participants received vaccine (6MHP+mBRAF+poly-ICLC) with a dose-escalation allocation of CDX-1140 …
Systemic lupus erythematosusCVDSLESystemic Lupuscardiovascular disease
…ease (CVD) via pro-inflammatory and pro-atherogenic mechanisms. Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a significantly inc…
Atrial fibrillationSLEOACoral anticoagulantsCroatian Institute for Public HealthAFUniversity HospitalparAF
…Objectives Atrial fibrillation (AF) is the most common cardiac arrhythmia in the general popul…
systemic lupus erythematosuscutaneous lupus erythematosuschilblain lupusSLElupus tumidusmixed connective tissue diseaseSCLEsystemic therapyCLEchronic discoid lupus erythematosus
…xed connective tissue disease (n=1), as well as 9 patients with systemic lupus erythematosus (SLE), were included. Additionally, 12 healthy controls were re…
SLEobinutuzumabhydroxychloroquineprednisoloneIVIgtacrolimuscyclophosphamideazathioprinerituximab
…has not previously been reported in SLE. Herein we describe two SLE cases with anti-neurofascin–positive AN and highlight robust re…
Karolinska University HospitalLMWHLDASAsystemic lupus erythematosusSLELMWH-treatedlupus nephritisantithrombotic prophylaxisMethods
…pregnancies in women with SLE followed between 2018 and 2022 at Karolinska University Hospital. Clinical, laboratory, and obstetric data were collected from m…
Belimumabsystemic lupus erythematosusBELlupus nephritisSLELNBAFF
…Objectives Belimumab (BEL) is an IgG1 antibody against the soluble form of B-cell ac…
voclosporinobinutuzumabbelimumabanifrolumabsystemic lupus erythematosusmycophenolate mofetilrituximabClass V diseaseEnlight-LN registryClass IV disease+2 more
…omitant immunosuppressive biologics in LN patients treated with voclosporin. This is notable given the unique and possibly synergistic effe…
SLEBelimumabBELGSK Study 116543SABLE registry
…to standard therapy, and reinforce the role of BEL in long-term SLE management.Funding GSK…